|
|
|
|
|
|
The latest neurology news from News Medical |
|
|
|
|
How innovation in dried blood spot testing is transforming neurological disease monitoring
Dried blood spot (DBS) testing is revolutionizing neurological disease monitoring by offering a low-cost, minimally invasive method for long-term tracking. Using just a finger prick, DBS enables at-home sample collection, eliminating the need for cold storage and simplifying logistics. Learn how this approach is particularly beneficial for managing neurodegenerative diseases, allowing for easier, more frequent monitoring over time.
| |
|
|
| |  | | Announcing a new publication for Acta Materia Medica journal. Neurologic disorders are the leading cause of illness and disability as a result of increased life expectancy and global population aging, highlighting the urgent need and great challenge for discovering neuroprotective agents with better efficacy and minimal side-effects. | | | | Scientists from St. Jude Children's Research Hospital and Washington University in St. Louis report mechanistic insights into the role of biomolecular condensation in the development of neurodegenerative disease. | | | | As the global population ages, the risk of developing neurodegenerative diseases such as dementia, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) continues to rise. But the molecular mechanisms behind the deterioration of brain cells have remained elusive. | | | | Explore how brain organoids are applied in neurological disease research and drug discovery. | | | | In this interview, NewsMedical speaks with Quanterix about blood spot testing for neurological applications. | |
|
|
| |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
| | How would you rate today's newsletter?
| |
|
|
|
|
|
|